After nearly twenty years with the current Good Clinical Practice (GCP) guidelines, ICH is publishing an addendum that will change definitions, principles and responsibilities for the future. These changes include new requirements of compliance and risk, many of which follow requirements in FDA guidelines. It is essential for pharmaceutical companies and clinical research organizations to stay up-to-date on these changes.
To read the full article from GetCRO, click here.